Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Renal FunctionHIV Infection
Interventions
OTHER

Tc99mDTPA renal clearance

"Tc99mDTPA renal clearance only for 200 patients~1. Plasma and urine 24 hr for creatinin, glucose, Creatinin clearance, Phosphatemia, uric acid, HCO3, protein, Microalbuminuria, ß2- microglobulinuria~2. serum creatinine prior and during TDF~3. TDF plasma levels ( only TDF use) using a validated high-performance liquid chromatography (HPLC)-mass method and stored PBMC for intracellular TDF levels~4. stored samples (PBMC) for pharmacogenomic study of transporter gene ie Organic Acid Transporter (OAT)~5. serum for cystanin C ( stored sample prior taking ARV and present time)~6. intensive 24 hours pharmacokinetic study of TDF in 20 patients"

Trial Locations (1)

10330

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Chulalongkorn University

OTHER

collaborator

Kirby Institute

OTHER_GOV

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER